Skip to main content

Table 3 Risk-based screening criteria among women in the consecutive sample when stratified by thyroid function testing

From: Screening for thyroid disease in pregnancy: a study of Danish clinical practice

 

Thyroid function testeda

Thyroid function not testedb

 

n

%

n

%

Pregnant womenc

81

 

211

 

Screening criteria, overall

DES criteria

37

45.7

41

19.4

 1 fulfilled

31

38.3

36

17.0

 2 or more fulfilled

6

7.4

5

2.4

ATA criteria

58

71.6

140

66.4

 1 fulfilled

24

29.6

62

29.4

 2 or more fulfilled

34

42.0

78

37.0

Screening criteria, specific

Maternal characteristics

 Age > 30 years

42

51.8

111

52.6

 BMI ≥ 40 kg/m2

 < 3

-

6

2.8

Reproductive history

 Multiple prior pregnancies (≥ 2)

6

7.4

30

14.2

 Previous preterm birthd

4

4.9

5

2.4

 Previous pregnancy lossd

20

24.7

55

26.2

 Recurrent pregnancy loss (≥ 3)d

 < 3

-

 < 3

-

 Fertility treatmentd

24

29.6

21

10.0

Family history

 Family history of thyroid diseased

 < 3

-

6

2.9

Disease history

    

 Use of amiodarone, lithium, or recent iodinated contrast

 < 3

-

 < 3

-

 History of radiation therapy of the head and neck area

 < 3

-

 < 3

-

 Type 1 diabetes

6

7.4

 < 3

-

 Other autoimmune diseases

 < 3

-

5

2.4

 Previous thyroid diseased

3

3.8

 < 3

-

  1. Abbreviations: DES Danish Endocrine Society, ATA America Thyroid Association
  2. aMeasurement of maternal thyroid-stimulating hormone (TSH) from 3 months prior to pregnancy or during the pregnancy
  3. bNo measurement of maternal thyroid-stimulating hormone (TSH) from 3 months prior to pregnancy or during the pregnancy
  4. cWomen included received no current treatment for thyroid disease and had available data on risk factors for thyroid disease
  5. dMissing data not included: previous preterm birth (n < 3), previous pregnancy loss (n < 3), recurrent pregnancy loss (n < 3), fertility treatment (n < 3), family history of thyroid disease (n < 3), previous thyroid disease (n = 4)